✦ LIBER ✦

Pooled analysis of the safety and tolerability of desvenlafaxine Succinate compared with placebo in the treatment of major depressive disorder

✍ Scribed by A.H. Clayton; S.G. Kornstein; L. Lamm; G. Rosas; K.A. Tourian

Book ID: 118439192
Publisher: Elsevier Science
Year: 2008
Tongue: French
Weight: 43 KB
Volume: 23
Category: Article
ISSN: 0924-9338
DOI: 10.1016/j.eurpsy.2008.01.321

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An integrated analysis of the efficacy o

An integrated analysis of the efficacy of desvenlafaxine succinate compared with placebo in the treatment of major depressive disorder

✍ M.E. Thase; S.G. Kornstein; R. Tummala; J.M. Germain; Q. Jiang; S. Ahmed; P.T. N 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 44 KB

Safety and Tolerability of Desvenlafaxin

Safety and Tolerability of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder

✍ Findling, Robert L.; Groark, James; Chiles, Deborah; Ramaker, Sara; Yang, Lingfe 📂 Article 📅 2014 🏛 Mary Ann Liebert 🌐 English ⚖ 403 KB

Reduction of anxiety symptoms in patient

Reduction of anxiety symptoms in patients with major depressive disorder treated with Desvenlafaxine Succinate: A pooled analysis

✍ K.A. Tourian; S. Ahmed; A. Patroneva; B. Zitek; J. Graepel; B. Pitrosky 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 44 KB

Age and gender analysis of baseline depr

Age and gender analysis of baseline depressive symptoms in patients with major depressive disorder treated with Desvenlafaxine Succinate or placebo

✍ S.G. Kornstein; M. Fava; K. Tourian; L. Lamm; Q. Jiang; A. Patroneva; S. Ahmed 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 43 KB

Safety and tolerability of duloxetine in

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials

✍ James I. Hudson; Madelaine M. Wohlreich; Daniel K. Kajdasz; Craig H. Mallinckrod 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

## Abstract ## Objective To examine the safety and tolerability of the antidepressant duloxetine across multiple studies for major depressive disorder (MDD). ## Method Safety data were integrated from the acute phases of eight double‐blind, placebo‐controlled trials in which patients were random

Efficacy, safety, and tolerability of de

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder*

✍ Liebowitz, Michael R.; Manley, Amy L.; Padmanabhan, Sudharshan K.; Ganguly, Rita 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 168 KB